is semaglutide coming off the market Novo cuts GLP-1 prices 70%, but revenue could grow in 2026 Weight-loss jab could be made

After the development of Zepbound and anticipated demand, the company expanded its manufacturing and quality control processes with distribution to retail and mail-order pharmacies

This accumulation chart tells you how drug levels build within a single dose level before they level off

Premier Protein and Orgain have also been focusing on high-protein, low-calorie drinks, appealing to consumers who need small but high-quality sources of protein, which can be more challenging for GLP-1 users with reduced appetite

Slowing a degenerative cascade requires altering pathology over years, often after enough neuronal loss that the clinical trajectory is already set

The insulin regimen in type 2 diabetes should be tailored to the individual to reach their individualized glycemic levels and to minimize risk of hypoglycemia

When you have a neurodegenerative disease, the train has left the station, she says